• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.62%

    Sarepta Therapeutics, Inc. (SRPT)

    -NasdaqGS
    14.19 Apr 29, 4:00PM EDT
    |Pre-Market : 14.95 Up 0.76 (5.36%) 9:17AM EDT - Nasdaq Real Time Price
    Prev Close:14.19
    Open:N/A
    Bid:15.20 x 100
    Ask:15.25 x 100
    1y Target Est:18.73
    Beta:1.21751
    Earnings Date:May 5 - May 9 (Est.)
    Day's Range:N/A - N/A
    52wk Range:8.00 - 41.97
    Volume:133,391
    Avg Vol (3m):4,428,040
    Market Cap:648.01M
    P/E (ttm):N/A
    EPS (ttm):-5.20
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    SRPT 0.00%648.01M
    GSK103.84B
    ALNY5.72B
    ISIS6.91B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):517.16
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-4.34
    Quarterly EPS Est (Mar-16) :-1.30
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):16.35

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback